Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-24 Sale | 2026-02-26 09:48 am | Voyager Therapeutics Inc. | VYGR | Swartz Robin COO & CBO | 6,458 | $3.77 | $24,347 | 199,738 (Direct) | View |
| 2026-02-24 Sale | 2026-02-26 09:47 am | Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO | 14,197 | $3.79 | $53,807 | 484,060 (Direct) | View |
| 2026-02-24 Sale | 2026-02-26 09:46 am | Voyager Therapeutics Inc. | VYGR | Jorgensen Nathan D. Chief Financial Officer | 4,668 | $3.77 | $17,598 | 151,416 (Direct) | View |
| 2026-02-24 Sale | 2026-02-26 09:44 am | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 4,174 | $3.76 | $15,694 | 145,718 (Direct) | View |
| 2026-02-18 Sale | 2026-02-20 4:04 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin COO & CBO | 3,882 | $3.44 | $13,354 | 206,196 (Direct) | View |
| 2026-02-18 Sale | 2026-02-20 4:03 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 3,301 | $3.44 | $11,355 | 149,892 (Direct) | View |
| 2026-02-18 Sale | 2026-02-20 4:01 pm | Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO | 11,732 | $3.41 | $40,006 | 498,257 (Direct) | View |
| 2026-02-10 Sale | 2026-02-11 4:32 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin COO & CBO | 4,569 | $3.85 | $17,591 | 210,078 (Direct) | View |
| 2026-02-10 Sale | 2026-02-11 4:30 pm | Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO | 12,192 | $3.78 | $46,086 | 509,989 (Direct) | View |
| 2026-02-10 Sale | 2026-02-11 4:30 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 3,525 | $3.85 | $13,571 | 153,193 (Direct) | View |
| 2025-10-03 Sale | 2025-10-07 4:30 pm | Voyager Therapeutics Inc. | VYGR | Jorgensen Nathan D. Chief Financial Officer | 7,666 | $4.78 | $36,643 | 123,834 (Direct) | View |
| 2025-08-18 Sale | 2025-08-20 2:09 pm | Voyager Therapeutics Inc. | VYGR | Ferguson Toby Chief Medical Officer | 19,000 | $3.73 | $70,870 | 138,914 (Direct) | View |
| 2025-04-02 Sale | 2025-04-04 4:10 pm | Voyager Therapeutics Inc. | VYGR | Ferguson Toby Chief Medical Officer | 10,086 | $3.43 | $34,595 | 157,914 (Direct) | View |
| 2025-04-02 Sale | 2025-04-04 4:08 pm | Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO | 10,885 | $3.43 | $37,336 | 430,931 (Direct) | View |
| 2025-02-20 Sale | 2025-02-24 4:21 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 3,305 | $4.26 | $14,079 | 215,718 (Direct) | View |
| 2025-02-20 Sale | 2025-02-24 4:20 pm | Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO | 11,702 | $4.24 | $49,616 | 731,816 (Direct) | View |
| 2025-02-20 Sale | 2025-02-24 4:19 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin COO & CBO | 3,894 | $4.25 | $16,550 | 312,147 (Direct) | View |
| 2025-02-11 Sale | 2025-02-12 4:22 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 5,413 | $4.45 | $24,088 | 81,023 (Direct) | View |
| 2025-02-11 Sale | 2025-02-12 4:21 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin COO & CBO | 6,950 | $4.45 | $30,928 | 102,291 (Direct) | View |
| 2025-02-11 Sale | 2025-02-12 4:20 pm | Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President & CEO | 16,644 | $4.45 | $74,066 | 308,518 (Direct) | View |
| 2025-02-11 Sale | 2025-02-12 4:19 pm | Voyager Therapeutics Inc. | VYGR | Fahey Sandell Jacquelyn Chief Legal Officer | 4,358 | $4.45 | $19,393 | 81,643 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-06 Option Award | 2026-02-10 4:33 pm | N/A 2036-02-06 | Voyager Therapeutics Inc. | VYGR | Ferguson Toby Chief Medical Officer | 255,000 | $0 | 393,914 (Direct) | View |
| 2026-02-06 Option Award | 2026-02-10 4:32 pm | N/A 2036-02-06 | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 187,000 | $0 | 310,718 (Direct) | View |
| 2026-02-06 Option Award | 2026-02-10 4:31 pm | N/A 2036-02-06 | Voyager Therapeutics Inc. | VYGR | Swartz Robin COO & CBO | 255,000 | $0 | 424,647 (Direct) | View |
| 2026-02-06 Option Award | 2026-02-10 4:30 pm | N/A 2036-02-06 | Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO | 488,750 | $0 | 924,681 (Direct) | View |
| 2026-02-06 Option Award | 2026-02-10 4:30 pm | N/A 2036-02-06 | Voyager Therapeutics Inc. | VYGR | Jorgensen Nathan D. Chief Financial Officer | 182,750 | $0 | 306,584 (Direct) | View |
| 2026-01-06 Option Award | 2026-01-08 6:10 pm | N/A 2036-01-06 | Voyager Therapeutics Inc. | VYGR | Shiferman Gregory L. SVP and General Counsel | 100,000 | $0 | 100,000 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-04 9:09 pm | N/A 2035-06-03 | Voyager Therapeutics Inc. | VYGR | Vitale Nancy Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-04 9:08 pm | N/A 2035-06-03 | Voyager Therapeutics Inc. | VYGR | SCANGOS GEORGE A Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-04 9:07 pm | N/A 2035-06-03 | Voyager Therapeutics Inc. | VYGR | PIERCE GLENN Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-04 9:04 pm | N/A 2035-06-03 | Voyager Therapeutics Inc. | VYGR | Onyia Jude Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-04 9:03 pm | N/A 2035-06-03 | Voyager Therapeutics Inc. | VYGR | MACKEY CATHERINE J Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-04 9:02 pm | N/A 2035-06-03 | Voyager Therapeutics Inc. | VYGR | Hyman Steven Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-04 9:00 pm | N/A 2035-06-03 | Voyager Therapeutics Inc. | VYGR | Higgins Michael J Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-04 8:59 pm | N/A 2035-06-03 | Voyager Therapeutics Inc. | VYGR | GERAGHTY JAMES A Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-04 8:58 pm | N/A 2035-06-03 | Voyager Therapeutics Inc. | VYGR | Colon Grace Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-24 4:21 pm | N/A 2035-02-21 | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 138,000 | $0 | 215,718 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-24 4:20 pm | N/A 2035-02-21 | Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO | 435,000 | $0 | 731,816 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-24 4:19 pm | N/A 2035-02-21 | Voyager Therapeutics Inc. | VYGR | Swartz Robin COO & CBO | 213,750 | $0 | 312,147 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-24 4:18 pm | N/A 2035-02-21 | Voyager Therapeutics Inc. | VYGR | Fahey Sandell Jacquelyn Chief Legal Officer | 124,500 | $0 | 206,143 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-24 4:16 pm | N/A 2035-02-21 | Voyager Therapeutics Inc. | VYGR | Ferguson Toby Chief Medical Officer | 189,000 | $0 | 294,000 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-24 4:15 pm | N/A 2035-02-21 | Voyager Therapeutics Inc. | VYGR | Jorgensen Nathan D. Chief Financial Officer | 154,500 | $0 | 234,500 (Direct) | View |